American Neurological Association 130th Annual Meeting in San Diego

September 19, 2005

Identifying and overcoming barriers to translating basic research from the laboratory to the clinic ... protecting brain cells in stroke ... understanding stem cells in neurologic disorders ... using commonalities among Alzheimer's, Parkinson's, and other neurodegenerative diseases to design treatments. These are some of the highlights of the 130th Annual Meeting of the American Neurological Association in San Diego, September 25 to 28, 2005, at the San Diego Marriot Hotel and Marina.

Leading researchers from around the world will present 11 platform talks and 260 refereed poster presentations at the world's preeminent neurology meeting. Symposium subjects will include:

Public Policy Symposium--Where's the Beef? Realizing the Promise of Laboratory Research--Rapid advancement in human genetics and other laboratory successes have not translated into similar progress in human therapeutics. In the Monday morning symposium, the NIH, the FDA, academic administrators, highly successful translational researchers, biotech venture capitalists, and entrepreneurs will discuss novel strategies aimed at speeding the journey to treatments.

Protecting Nerve Cells in Stroke -- Strokes and other brain injuries starve brain cells of oxygen. Presenters in the Monday afternoon symposium will discuss what is known about ischemic cell death, and how this knowledge can be used to protect and rescue brain cells from strokes.

Stem Cells: Surprises, Progress, and Controversy -- The Tuesday afternoon symposium will focus on one of the surprises of recent years in neurobiology--the fact that stem cells continue to be active and important in the health of the adult brain. Participants will discuss stem cells in the context of stroke and Parkinson's disease. The symposium will conclude with a presentation on the controversial California Institute for Regenerative Medicine, which will fund and oversee stem cell research in that state.

Exploiting Similarities in Neurodegenerative Diseases--Alzheimer's, Huntington's, Parkinson's, and other neurodegenerative diseases present with very different symptoms, but all involve the gradual death of select groups of brain cells. Researchers in these separate disorders have begun to identify common steps in the pathways to degeneration. In the Wednesday morning symposium, participants will review the state-of-the-art in neurodegenerative diseases and discuss efforts underway to design treatments.
-end-
News releases will be available to journalists at the Newswise website (www.newswise.com) approximately 5 days before the meeting. For more information, contact Crystal Weinberger at cweinberger@llmsi.com or 952-545-6284.

The American Neurological Association is the world's oldest and most prestigious neurological association. The 1,500 members of the ANA--selected from among the most respected academic neurologists and neuroscientists in North America and other countries--are devoted to furthering the understanding and treatment of nervous system disorders. The Annals of Neurology, published by the ANA, is the preeminent neurological journal worldwide.

For more information, visit www.aneuroa.org.

American Neurological Association

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.